Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial 1

This publication has 36 references indexed in Scilit:

• A Randomized Trial of Aspirin to Prevent Colorectal Adenomas
  New England Journal of Medicine, 2003
• A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal Cancer
  New England Journal of Medicine, 2003
• The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
  New England Journal of Medicine, 2000
• Long-Term Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Colorectal Adenomas
  Digestion, 2000
• Prevention by aspirin and its combination with α-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon
  Carcinogenesis: Integrative Cancer Research, 1999
• Aspirin use and reduced occurrence of large bowel adenomas: T.D. Tosteson, E.R. Greenberg, J.A. Baron, Dartmouth Medical School, Hanover, NH. For the Polyp Prevention Study Group
  Gastroenterology, 1995
• Diseases preceding colon cancer
  Digestive Diseases and Sciences, 1994
• Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer
  Archives of internal medicine (1960), 1994
• Low-Dose Aspirin and Incidence of Colorectal Tumors in a Randomized Trial
  JNCI Journal of the National Cancer Institute, 1993
• Prospective Study of the Frequency and Size Distribution of Polyps Missed by Colonoscopy
  JNCI Journal of the National Cancer Institute, 1990